SMi is proud to present their 4th annual conference on COPD, with presentations from the biggest players in the field. This year’s event promises to be a perfect forum for discussions and debates with key opinion leaders from industry and academia.

Key Benefits of Attending:

• Consider developments in the modelling and management of exacerbations of COPD
• Evaluate unique complexities of COPD pathophysiology
• Develop combination and oxygen therapies within COPD - learn about triple therapies and novel therapies within the treatment of COPD
• Hear from leading industry professionals on the current clinical trials process and rapid proof of concept studies
• Analyse all phases of the discovery process, from pre-clinical modelling, phase 2 studies all the way through to modelling clinical outcomes
• Network with and learn from key industry professional and research leading academics
• Discuss the latest in health economics for COPD drugs

For more information visit http://www.smi-online.co.uk/copd-conference50.asp or contact Fateja Begum on tel +44 0 207 827 6184 or email fbegum@smi-online.co.uk